[Group News] China Regenerative Medicine International Limited (Stock Code: 8158.HK) Fund Invested Completes Acquisition of U.S Cosmeceuticals Brand – Obagi. Hong Kong, [13 November 2017] – China Regenerative Medicine International Limited (“China Regenerative Medicine” or “the Company”, stock code: 8158.